exp3174 has been researched along with ramipril in 1 studies
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (ramipril) | Trials (ramipril) | Recent Studies (post-2010) (ramipril) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 2,151 | 606 | 509 |
| Protein | Taxonomy | exp3174 (IC50) | ramipril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.004 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.253 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunham, EW; Zhang, X; Zimmerman, BG | 1 |
1 other study(ies) available for exp3174 and ramipril
| Article | Year |
|---|---|
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation | 1995 |